Product
Selinexor + Bortezomib + Dexamethasone
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line TherapyStatus: Recruiting, Estimated PCD: 2028-03-01